Chronic sinusitis is prolonged inflammation of the paranasal sinuses that persists for more than 12 weeks despite treatment. Intranasal corticosteroids are typically used for treatment, followed by…
The highly entrenched generic market for major depressive disorder (MDD) patients poses a challenge for branded agents attempting to gain traction in the United States. The heterogeneous responses…
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. It is generally classified into three…
MARKET OUTLOOK Conventional therapies (5-ASAs, corticosteroids) are typically used to treat mild to moderate pediatric ulcerative colitis (UC), whereas tumor necrosis factor-alpha (TNF-α)…
Opioid-induced constipation (OIC) is the most common side effect of opioid therapy because of the distribution of opioid receptors throughout the GI tract. Although OTC treatment for OIC is common…
In the past decade, the TNF-α inhibitors Humira (AbbVie) and Enbrel (Amgen) and the IL-12/23 inhibitor Stelara (Janssen) have been leading the U.S. psoriasis biologics market. However, the recent…
This folder covers DRG’s Company & Drugs (C&D) data for Transplants which include market forecast (US, ROW and Global) and analysis on drug profie, drug group and therapy area.
Primary biliary cholangitis (PBC) is a disease characterized by autoimmune destruction of small bile ducts, thereby preventing bile mobilization and increasing hepatic bile content. These symptoms…
Gout is a chronic condition characterized by intermittent acute flares caused by elevated serum uric acid (sUA). Treatment of the painful acute flares is distinct from the chronic management of…
Idiopathic pulmonary fibrosis (IPF) is an orphan disease affecting approximately 50,000 people in the United States. It is characterized by an irreversible loss of lung function, leading to high…
DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each…
DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each…
DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each…
DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each…
DRG Epidemiology's coverage of hypertension comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of hypertension for each…
